Its activation serves to decrease apoptosis in renal tubular epithelial cells and to lower the generation of inflammatory mediators by activating Nrf2 and repressing NF-κB activity, thus offering protection against CI-AKI. This evidence concerns the gene NFE2L2 and acute kidney injury.